Experts look at policies and possible trade-offs to reduce drug prices

The experts weigh in on what policies and possible trade-offs are there if we were to adopt certain policies to reduce drug prices. Will there be negative consequences? Are we at risk of hampering drug innovation? Read attached article to find out what these three health policy experts consider if these policies are good or bad. Click here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.